Research graph
References from Literature review of myasthenia gravis complicated by myocardial damage. Local targets link to admitted publications; unresolved targets remain external evidence.
Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations.
10.3390/jcm10112235 · 2021 · External reference
The epidemiology of myasthenia gravis.
10.25122/jml-2020-0145 · 2021 · External reference
Incidence, mortality, and economic burden of myasthenia gravis in China: a nationwide population-based study.
2020 · External reference
A case report of myocardial failure type crisis in myasthenia gravis.
1979 · External reference
One case of myasthenia gravis crisis complicated with stress-induced cardiomyopathy and literature review.
2022 · External reference
One case of myocardial damage in patients with myasthenia gravis resembling the electrocardiogram of acute myocardial infarction.
2021 · External reference
One case of myasthenia gravis complicated with acute myocardial infarction.
2011 · External reference
A case report of myocardial infarction caused by pyridostigmine bromide in a patient with myasthenia gravis and literature review.
2023 · External reference
A case of cardiac hypertrophy caused by low-dose tacrolimus in the treatment of myasthenia gravis.
2022 · External reference
One case of misdiagnosis of acute myocardial infarction complicated with myasthenia gravis crisis.
2018 · External reference
Non-coronary myocardial infarction in myasthenia gravis: case report and review of the literature.
10.4330/wjc.v5.i7.265 · 2013 · External reference
Coronary spastic angina induced by anticholinesterase medication for myasthenia gravis--a case report.
10.1177/000331970005101209 · 2000 · External reference
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis.
10.1016/j.ijcard.2004.06.026 · 2005 · External reference
A case of transient left ventricular ballooning (“Takotsubo”-shaped cardiomyopathy) developed during plasmapheresis for treatment of myasthenic crisis.
2004 · External reference
Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report.
10.1186/1752-1947-4-393 · 2010 · External reference
Thymoma-associated myasthenia gravis with myocarditis.
2023 · External reference
Myocardial infarction after rituximab infusion.
10.1016/j.nmd.2013.03.014 · 2013 · External reference
A case report and 31-case study: does takotsubo cardiomyopathy in myasthenia gravis patients have a high mortality rate?
2022 · External reference
Rare case of iatrogenic myocardial infarction induced by use of pyridostigmine.
2020 · External reference
Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report.
10.1186/s12883-020-01901-2 · 2020 · External reference
Myasthenic crisis-induced Takotsubo cardiomyopathy in an elderly man: a case report of an underestimated but deadly combination.
10.4330/wjc.v13.i1.21 · 2021 · External reference
Non-ST elevation myocardial infraction after high dose intravenous immunoglobulin infusion.
10.1155/2009/861370 · 2009 · External reference
Transient ventricular dysfunction (Takotsubo cardiomyopathy).
10.1590/s0066-782x2005000400013 · 2005 · External reference
Broken heart syndrome during myasthenic crisis.
10.1097/cnd.0000000000000022 · 2014 · External reference
A case of sporadic late-onset nemaline myopathy associated with myasthenia gravis positive for anti-titin antibody and anti-Kv1.4 antibody.
10.5692/clinicalneurol.60.cn-001427 · 2020 · External reference
A broken heart: cardiac arrest as the initial presentation of myasthenic crisis.
2020 · External reference
A case of anti-MuSK positive MG with recurrent right-sided heart failure as the initial manifestation.
10.5692/clinicalneurol.cn-001475 · 2020 · External reference
Myasthenic crisis and Takotsubo syndrome: a non-chance relationship.
2012 · External reference
Broken heart syndrome in myasthenia gravis.
10.1002/mus.22220 · 2011 · External reference
Cushing’s syndrome developing myasthenia gravis with takotsubo cardiomyopathy after adrenalectomy: a case report.
10.1186/s12883-024-03866-y · 2024 · External reference
A rare case of overlapping durvalumab-induced myositis, takotsubo-like morphological changes caused by myocarditis, and myasthenia gravis.
10.2169/internalmedicine.3028-23 · 2024 · External reference
Takotsubo cardiomyopathy, or ‘broken-heart syndrome’, with concomitant myasthenic crisis.
10.11622/smedj.2019046 · 2019 · External reference
A myasthenic crisis complicated by a takotsubo cardiomyopathy.
2022 · External reference
An unfortunate case of takotsubo cardiomyopathy during plasmapheresis for myasthenia crisis.
2022 · External reference
Myasthenic crisis-induced Takotsubo cardiomyopathy: a case report.
10.1097/ms9.0000000000001723 · 2024 · External reference
An atypical Takotsubo cardiomyopathy in a typical myasthenic crisis.
10.1007/s10072-023-06844-3 · 2023 · External reference
Takotsubo cardiomyopathy in myasthaenia gravis crisis confirmed by cardiac MRI.
10.1136/bcr-2015-209631 · 2015 · External reference
Acute hypoxia from different clinical entities can potentially break the heart: takotsubo cardiomyopathy.
2023 · External reference
Takotsubo cardiomyopathy complicated with left ventricular thrombus in myasthenic crisis: a case report.
10.12659/ajcr.915415 · 2019 · External reference
Onset of Takotsubo 7 days after myasthenic crisis suggests an alternative trigger.
2022 · External reference
Tako-tsubo cardiomyopathy in a patient with myasthenia gravis crisis: a rare clinical association.
10.1136/bcr.06.2008.0182 · 2009 · External reference
A case report of recurrent takotsubo cardiomyopathy in a patient during myasthenia crisis.
2017 · External reference
Stress cardiomyopathy in a patient with myasthenia gravis.
2015 · External reference
Recurrent takotsubo cardiomyopathy precipitated by myasthenic crisis.
10.1016/j.ijcard.2011.06.129 · 2012 · External reference
Tako-Tsubo syndrome during normal human immunoglobolin perfusion.
10.1016/j.ancard.2011.08.003 · 2011 · External reference
Nivolumab-induced myasthenia gravis concomitant with myocarditis, myositis, and hepatitis.
2021 · External reference
Pembrolizumab-induced myasthenia gravis and myocarditis.
2024 · External reference
Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: a case report.
10.1002/ccr3.7039 · 2023 · External reference
Checkpoint inhibitor-induced myocarditis and myasthenia gravis in a recurrent/metastatic thymic carcinoma patient: a case report.
10.1093/ehjcr/ytaa051 · 2020 · External reference
Immune myocarditis overlapping with myasthenia gravis due to anti-PD-1 treatment for a chordoma patient: a case report and literature review.
10.3389/fimmu.2021.682262 · 2021 · External reference
Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: a case report and review of the literature.
10.3389/fmed.2022.950801 · 2022 · External reference
Myasthenia gravis and myocarditis induced by chemoimmunotherapy in locally advanced gastric cancer: a case report.
10.3892/etm.2024.12715 · 2024 · External reference
Immune checkpoint inhibitor-induced myasthenia gravis, myocarditis, and myositis: a case report.
10.1002/ccr3.8968 · 2024 · External reference
Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: a case report.
2020 · External reference
Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis-a case report.
10.21037/cdt-21-147 · 2021 · External reference
Camrelizumab-related myocarditis and myositis with myasthenia gravis: a case report and literature review.
10.3389/fonc.2021.778185 · 2021 · External reference
Severe myositis, myocarditis, and myasthenia gravis with elevated anti-striated muscle antibody following single dose of ipilimumab-nivolumab therapy in a patient with metastatic melanoma.
10.1155/2019/2539493 · 2019 · External reference
Acetylcholine receptor binding antibody-associated myasthenia gravis, myocarditis, and rhabdomyolysis induced by tislelizumab in a patient with colon cancer: a case report and literature review.
10.3389/fonc.2022.1053370 · 2022 · External reference
Myositis-myasthenia gravis overlap syndrome complicated with myasthenia crisis and myocarditis associated with anti-programmed cell death-1 (sintilimab) therapy for lung adenocarcinoma.
10.21037/atm.2020.01.79 · 2020 · External reference
Life-threatening immune checkpoint inhibitor-induced myocarditis and myasthenia gravis overlap syndrome treated with abatacept: a case report.
10.1136/bcr-2021-244334 · 2021 · External reference
Nivolumab-induced myocarditis concomitant with myasthenia gravis.
10.1159/000479958 · 2017 · External reference
The terrible triad of checkpoint inhibition: a case report of myasthenia gravis, myocarditis, and myositis induced by cemiplimab in a patient with metastatic cutaneous squamous cell carcinoma.
10.1155/2020/5126717 · 2020 · External reference
Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma.
10.1111/j.1440-1789.2012.01345.x · 2013 · External reference
Immune checkpoint inhibitor-related myasthenia gravis, myositis and myocarditis: a triad but not at the same time?
10.1093/qjmed/hcae006 · 2024 · External reference
Case report: the neuromusclar triad of immune checkpoint inhibitors: a case report of myositis, myocarditis, and myasthenia gravis overlap following toripalimab treatment.
10.3389/fcvm.2021.714460 · 2021 · External reference
Lethal immune myocarditis and myasthenia gravis due to Anti-PD-1 treatment for a bladder cancer patient: a case report and possible treatment inspiration.
2024 · External reference
Liver cancer with overlapping myasthenia gravis, myocarditis, seronegative autoimmune autonomic ganglionopathy, and myositis symptoms induced by atezolizumab.
10.2169/internalmedicine.1801-23 · 2024 · External reference
Presence of multiple autoimmune antibodies involved in concurrent myositis and myocarditis and myasthenia gravis without thymoma: a case report.
10.3389/fneur.2019.00770 · 2019 · External reference
Immune checkpoint inhibitor-induced myocarditis with concurrent myasthenia gravis.
2023 · External reference
Novel uses of complement inhibitors in myasthenia gravis-Two case reports.
10.1002/mus.28037 · 2024 · External reference
Pembrolizumab-induced myasthenia gravis with myocarditis in the setting of metastatic renal cell carcinoma.
2024 · External reference
Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report.
10.1186/s13256-022-03286-x · 2022 · External reference
Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review.
10.21037/apm-20-2620 · 2021 · External reference
Immune checkpoint inhibitor-mediated myasthenia gravis with focal subclinical myocarditis progressing to symptomatic cardiac disease.
10.1136/bcr-2019-232920 · 2020 · External reference
Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: a case report.
10.1097/md.0000000000033550 · 2023 · External reference
Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: a case report.
10.3892/ol.2011.501 · 2012 · External reference
Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma and myasthenia gravis.
10.1016/0167-5273(86)90124-5 · 1986 · External reference
Severe cardiotoxicity in 2 patients with thymoma receiving immune checkpoint inhibitor therapy: a case report.
10.1097/md.0000000000031873 · 2022 · External reference
Giant-cell myocarditis without a symptom of heart failure seen in a patient with myasthenia gravis and concurrent Hashimoto’s disease.
2001 · External reference
Fatal giant cell myocarditis after thymoma resection in myasthenia gravis.
10.1016/j.jtcvs.2005.09.035 · 2006 · External reference
A survival case of invasive thymoma accompanied by acute fulminant myocarditis.
10.1002/rcr2.6 · 2013 · External reference
Pyridostigmine-induced coronary artery spasm in early-onset myasthenia gravis: a case presentation and review of the literature.
10.1136/bcr-2022-249819 · 2022 · External reference
Intraoperative cardiogenic shock induced by refractory coronary artery spasm in a patient with myasthenia gravis: a case report.
10.12998/wjcc.v11.i36.8589 · 2023 · External reference
Myasthenia crisis following percutaneous coronary intervention in a patient with late onset myasthenia gravis: successful treatment of a unique case.
10.1007/s12928-012-0154-8 · 2013 · External reference
Myasthenic crisis and concomitant takotsubo syndrome complicated by shock.
10.2169/internalmedicine.3306-23 · 2024 · External reference
